Additional file 1: of Effects of erlotinib therapy on [11C]erlotinib uptake in EGFR mutated, advanced NSCLC

Supplementary data. Table S1. Parent fractions (%). Table S2. Whole blood SUV. Table S3. Tumor [11C]erlotinib V T and K1 values. Table S4. Tumor [15O]H2O flow values. Table S5. SUV and TBR values (unitless). (DOC 170 kb